$bmea bad data. No surprise

$xbi you'd have to be crazy to play any data catalyst in this environment. Funds looking for any news to exit.

$bmea intentionally preannounced an afternoon data pr for tomorrow to increase volume so they can pound atm.

$vrax only a matter of time before they issue a PR given all the attention on the potential Russia plague case and increasing spread of Ebola in Africa.

$sxtc up 500%. Low float mania might be back.

Long $vrax as a potential Russia plague fear ripper. Seems things are heating up over there with concerns growing. Only 1.3 million float

$crbu strategic alternatives lol

$crbu halt

$xbi tax loss selling has begun

Here's why the upcoming P1 $SCYX SCY-770 pk/pd at higher doses matters

Slight chance $scyx drops the news after close, but given how important the SCY-770 PK/PD is for the Phase 2 design and PoS I wager they'll drop it Monday morning in conjunction with a CC.

$SCYX kinda in shock at how many people missed the opportunity here. SCY-770 going into blockbuster indication and already significantly derisked due to mechanism of action. As mentioned yesterday the turnaround begins with imminent P1 data.

$scyx here we go

$scyx - both phase 1 readouts likely tomorrow. SCY-770 blockbuster potential in ADPDK and confident the turnaround story begins with the data release. One of those potential 5-10x returns by end of 2027 plays. Glad to be long at current valuation.

Congrats to $iova and the few bull accounts that never wavered on this one.

$acet don't say i didn't warn you

$scyx once market chews through prefunded warrants expect this to take off. Momentum set for SCY-770 data this week. Big market opportunity and I'm sure existing funds will add.

$scyx if they can show adequate PK/PD this week at the higher SCY-770 doses this is going a lot higher. There is a reason $akba employees coming over. Still trading 40% below cash

Rebought entire $scyx position back in $4.40s for kidney data this week